A comprehensive review of small molecule drugs approved by the FDA in 2025: advance and prospect.

Bai YR, Li R, Zhang XH, Seng DJ, Xu Y, Zhang SY, Yuan S

Open source

DOI
10.1080/14756366.2026.2704735
Published
2026 Dec
Container
Journal of enzyme inhibition and medicinal chemistry
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14756366.2026.2704735,
  title = {A comprehensive review of small molecule drugs approved by the FDA in 2025: advance and prospect.},
  author = {Bai YR and Li R and Zhang XH and Seng DJ and Xu Y and Zhang SY and Yuan S},
  year = {2026},
  journal = {Journal of enzyme inhibition and medicinal chemistry},
  doi = {10.1080/14756366.2026.2704735},
  url = {https://doi.org/10.1080/14756366.2026.2704735}
}

RIS

TY  - JOUR
TI  - A comprehensive review of small molecule drugs approved by the FDA in 2025: advance and prospect.
AU  - Bai YR
AU  - Li R
AU  - Zhang XH
AU  - Seng DJ
AU  - Xu Y
AU  - Zhang SY
AU  - Yuan S
PY  - 2026
JO  - Journal of enzyme inhibition and medicinal chemistry
DO  - 10.1080/14756366.2026.2704735
UR  - https://doi.org/10.1080/14756366.2026.2704735
ER  - 

APA

YR, B., R, L., XH, Z., DJ, S., Y, X., SY, Z., & S, Y. (2026). A comprehensive review of small molecule drugs approved by the FDA in 2025: advance and prospect.. Journal of enzyme inhibition and medicinal chemistry. https://doi.org/10.1080/14756366.2026.2704735

Source records